Lupin Limited has informed the Exchange regarding a press release dated December 13, 2024, titled "Lupin Acquires 3 Trademarks from Boehringer Ingelheim to Strengthen Diabetes Portfolio".
Lupin Limited has informed the Exchange regarding a press release dated December 13, 2024, titled "Lupin Acquires 3 Trademarks from Boehringer Ingelheim to Strengthen Diabetes Portfolio".